FDA Inspection 1173573 — Cecil M. Farrington, MD

Cecil M. Farrington, MD — FEI 3006771682

The FDA completed an inspection of Cecil M. Farrington, MD on Jun 9, 2022 in Salisbury, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 9, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Salisbury, NC (United States)

Additional Details

Clinical Investigator (CI)